直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Federal Circuit Denies Mandamus Petition, Confirming Non-Appealability of Institution Decisions Despite Parties’ Agreement to First Arbitrate Patent Validity

September 22, 2021

Authored and Edited by Y. Leon Lin; Sydney R. Kestle; Elizabeth D. Ferrill

In In re: MaxPower Semiconductor, Inc., No. 2021-146 (Fed. Cir. Sept. 8, 2021), the Federal Circuit denied MaxPower’s petition for mandamus seeking review of four PTAB decisions to institute IPR proceedings despite an agreement to first arbitrate patent validity.

MaxPower petitioned for mandamus review of the PTAB’s decisions to institute four IPR proceedings, arguing its agreement to arbitrate patent validity foreclosed PTAB review. A panel majority denied MaxPower’s petition. It first reasoned MaxPower had not established jurisdiction under the collateral order doctrine: “If MaxPower is truly not raising matters that are absolutely barred from appellate review under [35 U.S.C. §] 314(d) . . . , then MaxPower can meaningfully raise its arbitration-related challenged after the [PTAB]’s final written decisions.” The majority then rejected MaxPower’s argument that its appeals were authorized under 9 U.S.C. § 16(a)(1), which provides for appeals from certain arbitration-related orders. The Court found the PTAB’s decisions did not fall within any of the express statutory categories. Finally, the majority found MaxPower failed to show its mandamus petition was more than a means to avoid the statutory prohibition on appellate review of agency institution decisions. It noted MaxPower failed to show the PTAB clearly exceeded its authority because (i) the PTAB is not bound by a private contract between parties; and (ii) MaxPower failed to show how 35 U.S.C. § 294 deprives the PTAB of the authority to institute a review “when the statute does not by its terms task the agency with enforcing private arbitration agreements.”

Judge O’Malley dissented-in-part, finding the majority’s denial of a writ of mandamus in this case allows the PTAB to “add a new caveat to Congress’s clear instruction that agreements to arbitrate patent validity shall be ‘valid, irrevocable, and enforceable’—i.e., except during inter partes review.” In her view, 35 U.S.C. § 294 prevents PTAB review, at least until an arbitrator has determined the issue is not one for arbitration. And MaxPower has no other adequate method of obtaining relief because interlocutory appeals from institution decisions are barred under 35 U.S.C. § 314, and mandamus relief is “the only way to prevent the reviews from proceeding.”

Tags

Patent Trial and Appeal Board (PTAB), United States Court of Appeals for the Federal Circuit (CAFC), validity

Related Practices

Federal Circuit and Supreme Court Appeals

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

AI, Electronics, and Information Technology

Electrical and Computer Technology

Related Offices

Washington, DC

Contacts

Sydney R. Kestle
Partner
Washington, DC
+1 202 408 4241
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2021 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

Patent Litigation Europe 2027

January 18-20, 2027

Amsterdam

Panel Discussion

2026 Advanced Patent Law Institute

December 3-4, 2026

Stanford

Conference

IPBC Asia 2026

November 17-19, 2026

Tokyo

Conference

IAM Live: Navigating the UPC 2026

November 4, 2026

Paris

Conference

Life Sciences Patent Network North America Fall 2026

November 2-3, 2026

San Francisco

Conference

2026 ANA Masters of Advertising Law Conference

November 2-4, 2026

Huntington Beach

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Conference

2026 EDTX Bench Bar Conference

October 28-30, 2026

Fort Worth

Lecture

2026 Donald R. Dunner Endowed Lecture

October 27, 2026

Washington, DC

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP